Wells Fargo & Company Avita Medical, Inc. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Avita Medical, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 9,522 shares of RCEL stock, worth $92,077. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,522
Previous 8,517
11.8%
Holding current value
$92,077
Previous $116,000
31.03%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding RCEL
# of Institutions
86Shares Held
7.23MCall Options Held
19.8KPut Options Held
15.5K-
Black Rock Inc. New York, NY1.75MShares$16.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.41MShares$13.6 Million0.0% of portfolio
-
State Street Corp Boston, MA941KShares$9.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA543KShares$5.25 Million0.0% of portfolio
-
Awm Investment Company, Inc. New York, NY497KShares$4.81 Million1.19% of portfolio
About AVITA Medical, Inc.
- Ticker RCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 25,030,900
- Market Cap $242M
- Description
- AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...